NCT07189819 Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait
| NCT ID | NCT07189819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Post-stroke Hemiparesis |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-07-07 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-07-07 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare the performance of a novel data-driven model-predictive controller (MPC) based functional electrical stimulation (FES) system versus a conventional FES system for footdrop correction during treadmill and overground walking tasks in people post-stroke.
Eligibility Criteria
Inclusion Criteria: * \>6 months since stroke * cortical or subcortical stroke * able to walk 10-meters with or without an assistive device * sufficient cardiovascular health and ankle stability to walk on treadmill without ankle orthosis * passive ankle range of motion to benefit from dorsiflexor FES assistance * resting heart rate 40-100 bpm Exclusion Criteria: * cerebellar signs * score \>1 on question 1b (does not know the current month and age) and \>0 on question 1c (can not blink eyes and squeeze hands) on NIH Stroke Scale * inability to communicate with investigators * neglect/hemianopia * unexplained dizziness in past 6 months * sensory loss in paretic leg * musculoskeletal or medical conditions limiting walking * neurologic diagnoses other than stroke
Contact & Investigator
Trisha Kesar, PT, PhD
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT07189819 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 90 Years, studying Post-stroke Hemiparesis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07189819 currently recruiting?
Yes, NCT07189819 is actively recruiting participants. Contact the research team at trisha.m.kesar@emory.edu for enrollment information.
Where is the NCT07189819 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT07189819 clinical trial?
NCT07189819 is sponsored by Emory University. The principal investigator is Trisha Kesar, PT, PhD at Emory University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.